IL17RA expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.089400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.533200E-01
Normal-vs-Stage2
3.743000E-01
Normal-vs-Stage3
2.798400E-01
Normal-vs-Stage4
8.668200E-01
Stage1-vs-Stage2
4.320200E-01
Stage1-vs-Stage3
6.816400E-01
Stage1-vs-Stage4
1.909230E-01
Stage2-vs-Stage3
2.543400E-01
Stage2-vs-Stage4
4.437200E-01
Stage3-vs-Stage4
1.987000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.801400E-01
Normal-vs-AfricanAmerican
4.876600E-01
Normal-vs-Asian
5.159600E-01
Caucasian-vs-AfricanAmerican
9.078400E-01
Caucasian-vs-Asian
5.386800E-01
AfricanAmerican-vs-Asian
7.792400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.789200E-01
Normal-vs-Female
3.613600E-01
Male-vs-Female
4.843400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.571600E-01
Normal-vs-Age(41-60Yrs)
4.992200E-01
Normal-vs-Age(61-80Yrs)
2.604600E-01
Normal-vs-Age(81-100Yrs)
1.950440E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.847200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.841200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.883200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.405700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.890300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.249400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.490400E-01
Normal-vs-Daily Drinker
1.295230E-01
Normal-vs-Weekly Drinker
7.575400E-01
Normal-vs-Occasional Drinker
3.532200E-01
Normal-vs-Social Drinker
3.622000E-01
Non Drinker-vs-Daily Drinker
5.545800E-01
Non Drinker-vs-Weekly Drinker
7.737900E-02
Non Drinker-vs-Occasional Drinker
4.670200E-01
Non Drinker-vs-Social Drinker
5.533000E-01
Daily Drinker-vs-Weekly Drinker
1.888080E-02
Daily Drinker-vs-Occasional Drinker
1.858590E-01
Daily Drinker-vs-Social Drinker
2.505200E-01
Weekly Drinker-vs-Occasional Drinker
2.380600E-01
Weekly Drinker-vs-Social Drinker
2.380200E-01
Occasional Drinker-vs-Social Drinker
9.342600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.185600E-01
Normal-vs-Grade 2
3.029800E-02
Normal-vs-Grade 3
3.672100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.324600E-03
Grade 1-vs-Grade 3
5.944300E-03
Grade 1-vs-Grade 4
3.185600E-01
Grade 2-vs-Grade 3
5.552600E-01
Grade 2-vs-Grade 4
3.029800E-02
Grade 3-vs-Grade 4
3.672100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.456400E-01
Normal-vs-NonDiabetic
2.238200E-01
Diabetic-vs-NonDiabetic
5.300800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.519400E-01
Normal-vs-NoPancreatitis
2.577600E-01
Pancreatitis-vs-NoPancreatitis
5.674200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.103800E-01
Normal-vs-N1
3.787400E-01
N0-vs-N1
2.536200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.741150E-01
Normal-vs-TP53-NonMutant
1.488440E-01
TP53-Mutant-vs-TP53-NonMutant
3.792000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
